This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Stam WB, Aversa F, Kumar RN, Jansen JP.Economic evaluation of caspofungin versus liposomal amphotericin B for empiric antifungal treatment in patients with neutropenic fever in Italy. Value in Health 11: 830-841, No. 5, 1 Sep 2008
Rights and permissions
About this article
Cite this article
Caspofungin cost effective in neutropenic fever. Pharmacoecon. Outcomes News 568, 6 (2008). https://doi.org/10.2165/00151234-200805680-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805680-00014